Steven Cohen’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$94.1M Buy
893,201
+783,965
+718% +$73M 0.1% 224
2026
Q2
$8.19M Buy
109,236
+52,368
+92% +$3.36M 0.01% 1409
2026
Q1
$3.21M Sell
56,868
-796,511
-93% -$51.9M ﹤0.01% 1998
2025
Q4
$68.4M Buy
853,379
+810,328
+1,882% +$54.4M 0.08% 293
2025
Q3
$2.1M Sell
43,051
-395,273
-90% -$24.5M ﹤0.01% 1425
2025
Q2
$32.7M Buy
438,324
+17,394
+4% +$1.15M 0.06% 344
2025
Q1
$26.8M Buy
+420,930
New +$28.6M 0.06% 369
2024
Q3
– Sell
-219,024
Closed -$18.1M – 2133
2024
Q2
$18.1M Buy
219,024
+140,324
+178% +$12.3M 0.05% 426
2024
Q1
$6.72M Sell
78,700
-7,383
-9% -$579K 0.02% 873
2023
Q4
$7.36M Buy
+86,083
New +$7.44M 0.02% 787
2023
Q2
– Sell
-29,700
Closed -$2.46M – 2419
2023
Q1
$2.46M Sell
29,700
-344,146
-92% -$27.9M 0.01% 938
2022
Q4
$29.4M Sell
373,846
-183,693
-33% -$14.8M 0.1% 249
2022
Q3
$41.3M Buy
557,539
+148,642
+36% +$10.7M 0.16% 165
2022
Q2
$26.7M Buy
+408,897
New +$24.2M 0.11% 246
2021
Q4
– Sell
-266,100
Closed -$18.8M – 1173
2021
Q3
$18.8M Buy
266,100
+175,500
+194% +$11.1M 0.08% 325
2021
Q2
$6.04M Sell
90,600
-99,100
-52% -$7.01M 0.03% 573
2021
Q1
$21.1M Sell
189,700
-90,732
-32% -$11.2M 0.1% 250
2020
Q4
$33.3M Sell
280,432
-1,386,137
-83% -$149M 0.16% 176
2020
Q3
$145M Buy
1,666,569
+849,744
+104% +$74.3M 0.74% 15
2020
Q2
$73.2M Buy
816,825
+361,442
+79% +$36.5M 0.48% 46
2020
Q1
$45.4M Buy
+455,383
New +$49.4M 0.37% 64
2019
Q3
– Sell
-339,961
Closed -$40.9M – 1256
2019
Q2
$40.9M Sell
339,961
-519,449
-60% -$51.1M 0.21% 121
2019
Q1
$75.2M Buy
859,410
+55,648
+7% +$5.06M 0.34% 68
2018
Q4
$80.4M Buy
803,762
+796,862
+11,549% +$83.7M 0.39% 67
2018
Q3
$791K Buy
+6,900
New +$714K ﹤0.01% 867
2018
Q2
– Sell
-61,189
Closed -$4.48M – 1057
2018
Q1
$4.48M Sell
61,189
-416,011
-87% -$28.5M 0.02% 598
2017
Q4
$27.7M Buy
+477,200
New +$25.1M 0.12% 235
2017
Q1
– Sell
-82,058
Closed -$3.3M – 861
2016
Q4
$3.3M Sell
82,058
-603,742
-88% -$22.8M 0.02% 495
2016
Q3
$24.8M Buy
+685,800
New +$23.5M 0.17% 151

Other funds holding HAE

Steven Cohen's HAE Position: Q3 2026 in Review

Steven Cohen increased its Haemonetics (HAE) stake by 718% in Q3 2026, buying an estimated $73M and bringing the position to 893,201 shares worth $94.1M. The position accounts for 0.1% of the portfolio, ranked #224.

Steven Cohen first reported a position in HAE in Q3 2016 and has held it in 29 quarters since. The position peaked at $145M in Q3 2020. 358 funds tracked by Wall St. Rank hold HAE as of Q3 2026.

  • Steven Cohen held 893,201 shares of Haemonetics worth $94.1M as of Q3 2026.
  • Steven Cohen bought 783,965 Haemonetics shares in Q3 2026, an estimated $73M.
  • Haemonetics made up 0.1% of Steven Cohen's portfolio in Q3 2026, its #224 holding.
  • Steven Cohen first reported a position in Haemonetics in Q3 2016 and has held it in 29 quarters since.
  • Steven Cohen's Haemonetics position peaked at $145M in Q3 2020.
  • 358 funds tracked by Wall St. Rank held Haemonetics as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.